Biotechnology that delivers real benefits for New Zealanders

Some of Otago’s mid-career researchers will benefit from a new initiative to help New Zealand make the most of emerging biotechnology discoveries.

Newly appointed Co-Directors of Genetics Otago Dr Megan Leask and Associate Professor Michel Knapp have launched the Genetics Otago Impact Cluster programme to support staff working in genetic sciences to progress their careers.

The 2026 focus is researchers working in biotechnology and advanced technologies.

Five Faculty of Biomedical Sciences (BMS) and four Health Sciences researchers will participate in in-person workshops and be mentored to upskill, build connections, and accelerate their research through access to internal and external expertise, with a focus on networking, partnerships, and funding and activity-based skill development.

An important part of the cluster approach is to align genetics research to the New Zealand Government’s new science and research priorities.

Genetics Otago’s overarching goal as a University Research Centre is to build innovative genetic researchers capable of addressing the opportunities and challenges facing New Zealand and beyond.

Megan (Department of Physiology) says the Genetics Otago Impact Clusters come at a really important time for ECRs, where the funding landscape is increasingly uncertain.

“By building stronger networks, supporting collaboration, and connecting researchers with new partners and opportunities, this initiative will help position our researchers to navigate that current uncertainty and maximise their chances of success.”

Michel (Department of Anatomy) says exploring potential commercialisation pathways in biotechnology is increasingly important.

“The Impact Cluster programme is one way of making sure that we have support in place to make sure the researchers are in a place where they can thrive and their work has impact,” he says.